Showing results (111-120 of 387) with videos related to
Sort By:
Pageof 39
Clinical Pharmacology and Therapeutics|June 1, 1981
Cimetidine plasma concentration-response relationshipsR Gugler, G Fuchs, M Dieckmann, et al.Pharmacological Research|December 14, 2016
Advances in drug metabolism and pharmacogenetics research in AustraliaPeter I Mackenzie, Andrew A Somogyi, John O MinersXenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 1991
Thebaine O-demethylation to oripavine: genetic differences between two rat strainsG Mikus, A A Somogyi, F Bochner, et al.Clinical Pharmacology and Therapeutics|February 12, 2015
Pharmacogenetics of opioid responseA A Somogyi, J K Coller, D T BarrattXenobiotica; the Fate of Foreign Compounds in Biological Systems|July 11, 2015
Impact of CYP2C8*3 polymorphism on in vitro metabolism of imatinib to N-desmethyl imatinibMuhammad Suleman Khan, Daniel T Barratt, Andrew A SomogyiBritish Journal of Clinical Pharmacology|February 12, 1998
Characterization of the human cytochrome P450 enzymes involved in the metabolism of dihydrocodeineL C Kirkwood, R L Nation, A A SomogyiThe Australian and New Zealand Journal of Psychiatry|March 14, 2022
A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disordersSteve Kisely, Mark Connor, Andrew A Somogyi, et al.British Journal of Clinical Pharmacology|November 9, 2000
Kinetics and inhibition of the formation of 6beta-naltrexol from naltrexone in human liver cytosolS J Porter, A A Somogyi, J M WhiteClinical Pharmacology and Therapeutics|March 7, 2007
Pharmacogenetics of opioidsAndrew A Somogyi, Daniel T Barratt, Janet K CollerArzneimittel-Forschung|January 1, 1982
Pharmacokinetics and metabolism of antipyrine (phenazone) after intravenous and oral administrationM Eichelbaum, H R Ochs, G Roberts, et al.Pageof 39